Clinical trial
Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo…
NCT00149994 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00149994 |
|---|---|
| Title | Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients |
| Official title | DELTA Study Dutch Evaluation in Liver Transplantation To Assess the Efficacy of Cyclosporine A Microemulsion With C-2h Monitoring Versus Tacrolimus With Trough Monitoring in de Novo Liver Transplant Recipients |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Liver Transplant |
| Intervention type | Drug |
| Interventions | Cyclosporine A, Tacrolimus, Basiliximab, Methylprednisolone, Prednisone |
| Enrollment | 171 |
| Start date | Dec 1, 2002 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 8, 2005 |
| Last update posted | Apr 12, 2011 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: